About Elpis
Medicine meets engineering – for a safer future in stroke prevention.
What started as a doctoral thesis has evolved into a patented method for non-invasive stroke prevention – clinically tested and developed together with international neuroradiologists. Our analytical tools and algorithms are based on proprietary simulation models and are setting new benchmarks in medical diagnostics.
ELPIS stands for:
– validated research
– precise computational methods
– real progress in personalized medicine
Our team
Meet the Experts Powering ELPIS
Behind ELPIS are scientists, doctors and entrepreneurs with a shared vision.
Chief Medical Officer
Prof. Dr. Ilko Maier
Head of the Stroke Unit at the University Medical Center Göttingen
"I am a senior physician at the University Medical Center Göttingen and head of the Stroke Unit as well as the clinical stroke research group. As an experienced neurologist with a profound understanding of cerebrovascular diseases, I successfully translate scientific findings into clinical practice. My work combines medical excellence with innovative strength—particularly in personalized stroke prevention and data-driven therapy development."
CTO & Co-Founder
Dr. Aria Alimi
PhD in Engineering (Biomechanics)
"I am an expert in fluid mechanics, biomechanics, and cerebral perfusion simulation with over ten years of research experience. As the developer of the StroQ method, I combine cutting-edge CFD technology with clinical relevance and drive innovation at the intersection of engineering and medicine. My work stands for technical excellence, scientific depth, and a commitment to redefining prevention through simulation."
CEO & Co-Founder
Dr. Artjom Avakian
PhD in Engineering, MSc in Industrial Engineering and Management
"I am an innovation-driven technology expert with many years of experience leading complex R&D projects. I have built interdisciplinary expert teams, delivered successful high-tech innovations, and translated simulation, AI, and systems thinking into actionable product strategies. With entrepreneurial vision, I combine technical excellence with strategic execution."
What drives US
Our mission, values, and vision
Our mission is clear: we develop technologies that support physicians in identifying stroke risks early and preventing them in a targeted way – enabling a form of medicine that doesn’t just react, but acts proactively.
A stroke is often only diagnosed after it has already occurred. With precise risk assessment, many cases related to acute and chronic cerebral blood flow disorders can be prevented. This is our goal.
%201_compressed_153320.jpg)
RELIABLE DIAGNOSTICS – SCIENTIFICALLY BASED, CLINICALLY PROVEN.
If you want to go fast, go alone. If you want to go far, go together.
Our work is based on scientific excellence, ethical responsibility, and the goal of making state-of-the-art diagnostics intuitively usable for physicians. We focus on transparent research, clinical validation, and above all on close collaboration with experts from the field. This ensures that our solutions are reliable, precise, and applicable in real clinical practice.
HARNESSING UNIQUENESS – FOR EACH OF US. IN TIME.
Today, prevention is often general, reactive, and hardly personalized. Yet every patient is unique – with individual anatomical, genetic, and lifestyle-related characteristics.
Our goal is to enable individualized stroke prevention.
By working with each person’s uniqueness and making it clinically usable, we help individuals just as much as society as a whole.
We are convinced: prevention must not be a matter of chance. It has to be individualized, evidence-based – and accessible.